Activation of the hemostatic system during thrombolytic therapy
- 16 December 1993
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 72 (19) , G59-G65
- https://doi.org/10.1016/0002-9149(93)90109-p
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.Journal of Clinical Investigation, 1988
- Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysisAmerican Heart Journal, 1987
- Tissue plasminogen activator promotes platelet disaggregation in plasma.Journal of Clinical Investigation, 1987
- Intracoronary prostaglandin E1 plus streptokinase in acute myocardial infarctionThe American Journal of Cardiology, 1986
- Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarctionThe American Journal of Cardiology, 1986
- Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.Circulation, 1984
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Protection of factor Xa from neutralization by the heparin-antithrombin complex.Journal of Clinical Investigation, 1983
- Platelet release and thromboxane synthesis in symptomatic coronary artery disease.Circulation, 1982